SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 9/23/2017 3:12:50 PM - Followers: 33 - Board type: Free - Posts Today: 0
SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Pr... 09/22/2017 06:10:00 PM
BMY News: AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid ... 09/22/2017 07:00:00 AM
BMY News: AbbVie & Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tu... 09/22/2017 06:59:00 AM
BMY News: Japan Ministry of Health, Labor & Welfare Approves Opdivo (nivolumab) for the Treatment of Patients with Unresectable Advance... 09/22/2017 05:00:00 AM
BMY News: Bristol-Myers Squibb to Take Part in Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference 09/21/2017 06:59:00 AM
PostSubject
#649   True, I was wrong and thought if they Johnny_C 09/23/17 03:12:50 PM
#648   But did you read PFE CFO comments at DewDiligence 09/23/17 02:21:51 PM
#647   Ok. Looks like I was wrong about Johnny_C 09/23/17 10:07:32 AM
#646   Japan approves Opdivo monotherapy in second-line gastric cancer: DewDiligence 09/22/17 10:40:52 AM
#645   BMY withdraws Opdivo MAA in second-line HCC: DewDiligence 09/15/17 09:33:25 AM
#644   MRTX data in NSCLC PD-1 failures: DewDiligence 09/14/17 05:24:45 PM
#643   Good article but as usual several inaccuracies Johnny_C 09/09/17 12:28:28 PM
#642   https://seekingalpha.com/article/4105430-bristol-myers-squibb-gets-huge-boost-on Inoviorulez 09/08/17 04:10:29 PM
#641   This is getting a bit crazy now! Options Johnny_C 09/07/17 02:33:27 PM
#640   Could be blockbuster for sure! Johnny_C 09/07/17 10:11:01 AM
#639   First hour volume will be the same as Johnny_C 09/07/17 10:10:19 AM
#638   BMY flying. If someone wants to Johnny_C 09/07/17 09:44:01 AM
#637   The 41.6% figure refers to the Opdivo/Yervoy ORR DewDiligence 09/07/17 09:39:36 AM
#636   I now see an ORR of ~ 40% north40000 09/07/17 09:26:39 AM
#635   The PR does not report that info, but DewDiligence 09/07/17 09:24:37 AM
#634   What was the RRRs of all patients in north40000 09/07/17 09:21:12 AM
#633   Good news just keeps on coming! Johnny_C 09/07/17 09:15:33 AM
#632   CHECKMATE-214 in RCC stopped for superior efficacy—Opdivo/Yervoy superior DewDiligence 09/07/17 09:01:55 AM
#631   Volume twice 10 day moving average yesterday. Seeking Johnny_C 09/01/17 09:22:24 AM
#630   Early morning, heavy volume. Pharma Stocks waking Johnny_C 08/31/17 10:05:09 AM
#629   Bmy flying up again, this is 9 or Johnny_C 08/30/17 02:15:59 PM
#628   Good luck. 9 straight positive days. Johnny_C 08/29/17 03:02:14 PM
#627   Out of BMY @ $58.99. No reflection on chmcnfunds 08/29/17 12:05:44 PM
#626   Bristol-Myers Squibb and Pfizer Alliance Announce Real-World Observational chmcnfunds 08/29/17 09:01:28 AM
#625   One of the reasons why GILD has been Johnny_C 08/29/17 07:44:45 AM
#624   Neat chart... I just googled top 10 mergers... Johnny_C 08/28/17 10:50:05 AM
#623   30 to 40% premiums [or higher] seem to DewDiligence 08/28/17 10:24:50 AM
#622   30 to 40% premiums seem to be normal Johnny_C 08/28/17 10:21:45 AM
#621   You are right I read 190, Johnny_C 08/28/17 10:10:14 AM
#620   Nitpick: The GILD-KITE buyout premium was 29% (not 37%). DewDiligence 08/28/17 10:03:50 AM
#619   Correction...GILD could still be in the running for Johnny_C 08/28/17 09:32:31 AM
#618   Looks like Eliquos is going to be the Johnny_C 08/28/17 08:09:13 AM
#617   NO BMY SOUP FOR GILD.... Looks like they Johnny_C 08/28/17 07:50:02 AM
#616   Interesting the move up...considering the last news tanked Johnny_C 08/24/17 10:28:52 AM
#615   Has moved into overbought, so suspect upward movement chmcnfunds 08/24/17 10:14:50 AM
#614   Another up day for BMY on low low Johnny_C 08/23/17 03:44:41 PM
#613   Up quite a bit on no news and Johnny_C 08/23/17 11:58:43 AM
#612   Hadn't paid attention to the low volume until chmcnfunds 08/23/17 09:34:58 AM
#611   Almost all big pharma up big and virtually Johnny_C 08/22/17 03:27:18 PM
#610   All big pharma up big today! BMY Johnny_C 08/22/17 11:45:34 AM
#609   They say 40% upside possible, that is on Johnny_C 08/18/17 12:46:06 PM
#608   Bristol-Myers Squibb's (BMY) Nivolumab Receives FDA Orphan Designation chmcnfunds 08/18/17 09:16:29 AM
#607   https://seekingalpha.com/article/4099450-bristol-myers-squibb-combination-treatm Inoviorulez 08/16/17 06:22:42 PM
#606   BMY’s stock is too cheap, says Barron’s: DewDiligence 08/16/17 04:06:44 PM
#605   Bristol-Myers shares sink after another setback for its chmcnfunds 08/16/17 10:47:30 AM
#604   Glad the pps is recovering pre-market. While disappointing chmcnfunds 08/16/17 09:19:39 AM
#603   Musings on Opdivo/Yervoy results in RCC: #msg-133869270. DewDiligence 08/15/17 09:00:36 PM
#602   https://seekingalpha.com/article/4099033-bristol-myers-squibb-hiv-franchise-neve Inoviorulez 08/15/17 07:00:02 PM
#601   So much for $58. chmcnfunds 08/15/17 04:40:44 PM
#600   Consensus Ratings for Bristol-Myers Squibb Company (NYSE:BMY) (How chmcnfunds 08/10/17 09:09:48 AM
PostSubject